David Lillicrap, MD, discusses AAV gene therapy in a canine hemophilia model

• Date : 21/07/2021
• 8    
  0

6 Month Data From the Phase 3 Etranacogene Dezaparvovec HOPE-B Gene Therapy Trial

• Date : 21/07/2021
• 1    
  0

Dr. Steven W. Pipe discusses the latest on BAY 2599023

• Date : 21/07/2021
• 1    
  0

Valoctocogene Roxaparvovec AAV Gene Transfer for Severe Hemophilia: Results From Phase 3 Trial

• Date : 21/07/2021
• 1    
  0

An update on HOPE B Gene Therapy Trial from Stevne Pipe, MD

• Date : 21/07/2021
• 0    
  0

Liver Safety Case Report From the Phase 3 HOPE-B Gene Therapy Trial in Adults With Hemophilia B

• Date : 21/07/2021
• 0    
  0

Congrès ParkourS 2025

• Date : 30/01/2025
• 436    
  0

9ème Journée Nationale Maladies Rares Immuno-Hématologiques - MaRIH 2023

• Date : 30/06/2023
• 3583    
  6

International Society on Thrombosis and Haemostasis congress - ISTH 2023

• Date : 24/06/2023
• 5132    
  0

The European Hematology Association - EHA 2023

• Date : 08/06/2023
• 8351    
  0

MDS - 17th International Congress on Myelodysplastic Syndromes

• Date : 03/05/2023
• 12878    
  0